Latest News
National Institute of Health (NIH) awards Aracari Biosciences to commercialize bone marrow platform that models in vivo drug responses
Aracari Biosciences, Inc. (“Aracari”) announced that it has received a grant from the National Institute of Health to further develop Aracari’s proprietary human bone marrow technology that models in vivo drug responses.
National Science Foundation (NSF) awards Aracari Biosciences Phase II SBIR grant to commercialize the Vasoreactive Vascularized Micro-Organ (VMO-VA) platform
Aracari Biosciences, Inc. announces a Phase II Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) to commercialize its proprietary Vasoreactive Vascularized Micro-Organ (VMO-VA) platform.
National Institute of Health (NIH) awards Aracari Biosciences to commercialize bone marrow platform that models in vivo drug responses
Aracari Biosciences, Inc. (“Aracari”) announced that it has received a grant from the National Institute of Health to further develop Aracari’s proprietary human bone marrow technology that models in vivo drug responses.
National Science Foundation (NSF) awards Aracari Biosciences Phase II SBIR grant to commercialize the Vasoreactive Vascularized Micro-Organ (VMO-VA) platform
Aracari Biosciences, Inc. announces a Phase II Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) to commercialize its proprietary Vasoreactive Vascularized Micro-Organ (VMO-VA) platform.
